KYMR
Price
$56.25
Change
+$2.51 (+4.67%)
Updated
Sep 26 closing price
Capitalization
4.02B
33 days until earnings call
TRDA
Price
$5.80
Change
+$0.22 (+3.94%)
Updated
Sep 26 closing price
Capitalization
220.62M
45 days until earnings call
Interact to see
Advertisement

KYMR vs TRDA

Header iconKYMR vs TRDA Comparison
Open Charts KYMR vs TRDABanner chart's image
Kymera Therapeutics
Price$56.25
Change+$2.51 (+4.67%)
Volume$1.25M
Capitalization4.02B
Entrada Therapeutics
Price$5.80
Change+$0.22 (+3.94%)
Volume$297.03K
Capitalization220.62M
KYMR vs TRDA Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. TRDA commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and TRDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (KYMR: $56.25 vs. TRDA: $5.80)
Brand notoriety: KYMR and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 171% vs. TRDA: 96%
Market capitalization -- KYMR: $4.02B vs. TRDA: $220.62M
KYMR [@Biotechnology] is valued at $4.02B. TRDA’s [@Biotechnology] market capitalization is $220.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • TRDA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than TRDA.

Price Growth

KYMR (@Biotechnology) experienced а +14.49% price change this week, while TRDA (@Biotechnology) price change was +7.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

TRDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.02B) has a higher market cap than TRDA($221M). KYMR YTD gains are higher at: 39.821 vs. TRDA (-66.455). TRDA has higher annual earnings (EBITDA): -92.26M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. TRDA (354M). TRDA has less debt than KYMR: TRDA (54.7M) vs KYMR (85.7M). TRDA has higher revenues than KYMR: TRDA (79.5M) vs KYMR (44.7M).
KYMRTRDAKYMR / TRDA
Capitalization4.02B221M1,820%
EBITDA-267.03M-92.26M289%
Gain YTD39.821-66.455-60%
P/E RatioN/A10.05-
Revenue44.7M79.5M56%
Total Cash665M354M188%
Total Debt85.7M54.7M157%
TECHNICAL ANALYSIS
Technical Analysis
KYMRTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 26 days ago
88%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGNCX39.900.74
+1.89%
Victory Global Energy Transition C
MEFFX13.600.12
+0.89%
MassMutual Mid Cap Growth R4
APHSX37.970.32
+0.85%
Artisan Small Cap Institutional
TCBAX9.260.06
+0.65%
Covered Bridge A
RSLAX62.540.23
+0.37%
American Funds SMALLCAP World R1

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+4.68%
NRIX - KYMR
67%
Closely correlated
+7.20%
VERA - KYMR
58%
Loosely correlated
+4.60%
CGON - KYMR
55%
Loosely correlated
+2.91%
RGNX - KYMR
54%
Loosely correlated
+3.10%
NUVL - KYMR
54%
Loosely correlated
+4.99%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+3.94%
XNCR - TRDA
53%
Loosely correlated
+12.00%
CRNX - TRDA
52%
Loosely correlated
+27.92%
NRIX - TRDA
49%
Loosely correlated
+7.20%
VYGR - TRDA
48%
Loosely correlated
+10.51%
KYMR - TRDA
48%
Loosely correlated
+4.68%
More